Sold Out

A healthy gut starts with a strong intestinal barrier—and that barrier depends on butyrate. A short-chain fatty acid (SCFA) produced when certain beneficial gut bacteria ferment dietary fiber, butyrate fuels colon cells, supports a balanced microbiome, and promotes the formation of tight junctions between cells to strengthen intestinal integrity.
Unfortunately, only about 6% of Americans consume enough fiber.1 Low-fiber diets lead to a loss of beneficial bacteria-- particularly Anaerostripes caccae—which results in insufficient butyrate production and a weakened gut barrier.
Native to the human gut, Anaerostripes caccae is one of the few species capable of producing butyrate. Individuals with higher levels of these microbes tend to have better digestive health and fewer food sensitivities.
Direct butyrate production
Available exclusively through Maypro, CLB101™ is the first and only Anaerostripes caccae probiotic available for the dietary supplement market. Unlike conventional probiotics in the market such as lactobacillus or bifidobacterium species—which do not generate butyrate— CLB101™ acts as a continuous, natural source of butyrate to mimic the body’s own butyrate cycle.* In fact, Anaerostripes caccaecan supercharge conventional probiotics by converting their waste products (lactate and acetate) into butyrate.
Better than other probiotics
Most conventional probiotics support gut balance indirectly by crowding out unwanted microbes, but none produce butyrate.* CLB101™ stands apart from other probiotics, because it directly generates butyrate in the colon to support gut health.*
Better than butyrate ingredients alone
Oral butyrate (e.g., sodium butyrate) supplementation is hindered by an unpleasant smell and odor, as well as, stability issues. It is largely absorbed in the upper GI tract, so little reaches the colon. Newer forms (e.g., tributyrin) exist, but clinical evidence of meaningful outcomes remains limited, likely because the dose required for efficacious supplementation would be prohibitively large. Unlike these supplements, CLB101™ recreates the body's natural butyrate cycle with continuous biological production of butyrate directly within the lower GI tract where bacteria reside.*
Designed for real-world viability
While commercial production of many next-generation probiotics is often fraught with challenges, CLB101™ has been developed as an oxygen-tolerant powder that enables practical manufacturing, storage, and formulation while targeting delivery to the colon.
CLB101™ benefits:
CLB101™ is:
Researched benefits
Preclinical research shows that the Anaerostipes caccaespecies—including CLB101™, its clinically developed strain—supports gut health in several ways:
Increases butyrate concentration in the lower GI tract*
Readily colonizes the gut for prolonged periods*2
Helps prevent reactions to commonly challenging foods*2,3
Supports a healthy immune response in the gut*
Additionally, a double-blind, placebo-controlled clinical trial is underway to evaluate the safety and efficacy of CLB101™ in adults with self-reported GI issues.*



)
CLB101™ takes up residence in the colon and acts as a continuous source of butyrate by metabolizing prebiotic fiber and bacterial byproducts, such as acetate and lactate.⁴
CLB101™ is manufactured in a GMP-certified
facility and is third-party tested for purity. Demonstrated safe in Phase I and II toxicology studies, it is self-affirmed GRAS, free of allergens, non-GMO, and suitable for vegetarians and vegans.
1. U.S. Department of Agriculture, Department of Health and Human Services. Scientific Report of the 2025
Dietary Guidelines Advisory Committee. U.S. Department of Agriculture, Agricultural Research Service; 2025.
2. Hesser LA, Puente AA, Arnold J, et al. Cell Host Microbe. 2024;32(7):1163-1176.e6. doi:10.1016/j.chom.2024.05.019
3. Feehley T, Plunkett CH, Bao R, et al. Nat Med. 2019;25(3):448-453. doi:10.1038/s41591-018-0324-z
4. Vanhoutvin S a. LW, Troost FJ, Kilkens TOC, et al. Neurogastroenterol Motil.
2009;21(9):952-e76. doi:10.1111/j.1365-2982.2009.01324.x